Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours
2005 · European Journal of Cancer · 542 citations
https://doi.org/10.1016/j.ejca.2005.08.032
P
PHM de Mulder
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
45
Papers
1.9K
Citations
18
h-index
20
i10-index
PHM de Mulder is an academic researcher. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Ovarian cancer diagnosis and treatment & Renal cell carcinoma treatment. The author has an h-index of 18, co-authored 39 publications.
Papers by this author
worksA phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
2004 · British Journal of Cancer · 173 citations
https://doi.org/10.1038/sj.bjc.6601617
Psychosocial interventions for patients with advanced cancer – a systematic review of the literature
2004 · British Journal of Cancer · 142 citations
https://doi.org/10.1038/sj.bjc.6602103
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
2004 · Annals of Oncology · 86 citations
https://doi.org/10.1093/annonc/mdh145
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat